3 months to expiry Ghana · FDA Ghana

Sodicrom DS Eye Drops

Sodium Oninoglyate

FDA/SD.233-080965 Sodium Oninoglyate 4%w/w

What it does

Oninoglyate is a medication used to treat various health conditions. It is important to follow your healthcare provider's instructions when using this medicine.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.233-080965
Registration date
2023-08-16
Expiry date
2026-09-01
Status
3 months to expiry
Active ingredient
Sodium Oninoglyate
Dosage form
Sodium Oninoglyate
Strength
4%w/w
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Suyaash Pharmacuticals Limites
Applicant / LTR
Samospharma ltd
Country of origin
-
Manufacturer location
216/5-6 ,Village Khundh,Vansda Road Taluka Chikhli Dist Navsari Khundh, Chikhli, Khundh, Gujarat 396521, India

Source: Food and Drugs Authority · fetched 2026-04-18 08:48:20 · updated 2026-09-01 04:00:28

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Oninoglyate is a medication used to treat various health conditions. It is important to follow your healthcare provider's instructions when using this medicine.

How it works

Oninoglyate works by targeting specific processes in the body to help manage your condition.

Who it's for

This medicine is prescribed for individuals with certain medical conditions, as determined by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: oninoglyate

Oninoglyate is an investigational drug that is being studied for its potential role in treating various medical conditions. It is not widely recognized in established pharmacopoeias or formularies, and specific clinical use information may be limited due to its experimental status. As such, its pharmacological profile, including its mechanism of action, pharmacodynamics, and pharmacokinetics, is not fully characterized in available literature.

Dosage

Children: Refer to specific clinical guidelines or investigational protocols for pediatric dosing information, as no standardized pediatric dosing is available.

Adults: Refer to specific clinical guidelines or investigational protocols for dosing information, as no standardized adult dosing is available.

Mechanism of action

The precise mechanism of action of oninoglyate is not well documented. However, it is hypothesized to interact with specific cellular pathways or receptors that may influence disease processes. Further research is required to elucidate its exact biochemical interactions.

Pharmacodynamics

Pharmacodynamics data for oninoglyate are currently sparse. Generally, the drug may exhibit effects depending on its interaction with target cells, influencing physiological responses and potentially modulating disease progression. The impact of oninoglyate on cellular signaling cascades or metabolic pathways remains to be fully established.

Pharmacokinetics

Limited pharmacokinetic data is available for oninoglyate. Typically, pharmacokinetics encompass the absorption, distribution, metabolism, and excretion of a drug. For oninoglyate, further studies are necessary to determine its bioavailability, half-life, and the influence of factors such as age, sex, and comorbidities on its pharmacokinetic profile.

Pregnancy

The safety of oninoglyate during pregnancy has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether oninoglyate is excreted in human breast milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from direct light. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.